1.Terminally Differentiating Eosinophils Express Neutrophil Primary Granule Proteins as well as Eosinophil-specific Granule Proteins in a Temporal Manner.
Karam KIM ; Sae Mi HWANG ; Sung Min KIM ; Sung Woo PARK ; Yunjae JUNG ; Il Yup CHUNG
Immune Network 2017;17(6):410-423
Neutrophils and eosinophils, 2 prominent granulocytes, are commonly derived from myelocytic progenitors through successive stages in the bone marrow. Our previous genome-wide transcriptomic data unexpectedly showed that genes encoding a multitude of neutrophil primary granule proteins (NPGPs) were markedly downregulated during the end period of eosinophilic terminal differentiation when cord blood (CB) cluster of differentiation (CD) 34+ cells were induced to differentiate toward the eosinophil lineage during a 24-day culture period. Accordingly, this study aimed to examine whether NPGP genes were expressed on the way to eosinophil terminal differentiation stage and to compare their expression kinetics with that of genes encoding eosinophil-specific granule proteins (ESGPs). Transcripts of all NPGP genes examined, including proteinase 3, myeloperoxidase, cathepsin G (CTSG), and neutrophil elastase, reached a peak at day 12 and sharply declined thereafter, while transcript of ESGP genes including major basic protein 1 (MBP1) attained maximum expression at days 18 or 24. Growth factor independent 1 (GFI1) and CCAAT/enhancer-binding protein α (C/EBPA), transactivators for the NPGP genes, were expressed immediately before the NPGP genes, whereas expression of C/EBPA, GATA1, and GATA2 kinetically paralleled that of eosinophil granule protein genes. The expression kinetics of NPGPs and ESGPs were duplicated upon differentiation of the eosinophilic leukemia cell line (EoL-1) immature eosinophilic cells. Importantly, confocal image analysis showed that CTSG was strongly coexpressed with MBP1 in differentiating CB eosinophils at days 12 and 18 and became barely detectable at day 24 and beyond. Our results suggest for the first time the presence of an immature stage where eosinophils coexpress NPGPs and ESGPs before final maturation.
Bone Marrow
;
Cathepsin G
;
Cell Line
;
Eosinophils*
;
Fetal Blood
;
Granulocytes
;
Hypereosinophilic Syndrome
;
Kinetics
;
Leukocyte Elastase
;
Myeloblastin
;
Neutrophils*
;
Peroxidase
;
Trans-Activators
2.Different Protein Expressions between Peripheral Ameloblastoma and Oral Basal Cell Carcinoma Occurred at the Same Mandibular Molar Area.
Korean Journal of Pathology 2014;48(2):151-158
Peripheral ameloblastoma (PA) in gingiva is rare and often confused with oral basal cell carcinoma (OBCC). The tissues of one case of PA and one case of OBCC with the same mandibular molar area affected were compared via an immunohistochemical examination using 50 antisera. The PA and OBCC showed similar proliferation of basaloid epithelial strands, but toluidine blue staining revealed that the PA had pinkish juxta-epithelial myxoid tissue, whereas the OBCC was infiltrated by many mast cells. Immunohistochemical comparisons showed that the PA was strongly positive for ameloblastin, KL1, p63, carcinoembryonic antigen, focal adhesion kinase, and cathepsin K, and slightly positive for amelogenin, Krox-25, E-cadherin, and PTCH1, whereas the OBCC was not. On the other hand, the OBCC was strongly positive for EpCam, matrix metalloprotease (MMP)-1, alpha1-antitrypsin, cytokeratin-7, p53, survivin, pAKT1, transforming growth factor-beta1, NRAS, TGase-1, and tumor nescrosis factor-alpha, and consistently positive for beta-catenin, MMP-2, cathepsin G, TGase-2, SOS-1, sonic hedgehog, and the beta-defensins-1, -2, -3, while the PA was not. These data suggest that the tumorigeneses of PA and OBCC differ, and that PAs undergo odontogenic differentiation and generate oncogenic signals for infiltrative growth and bone resorption, whereas OBCCs undergo basaloid epidermal differentiation as a result of growth factor/cytokine-related oncogenic signals.
Ameloblastoma*
;
Amelogenin
;
beta Catenin
;
Bone Resorption
;
Cadherins
;
Carcinoembryonic Antigen
;
Carcinogenesis
;
Carcinoma, Basal Cell*
;
Cathepsin G
;
Cathepsin K
;
Focal Adhesion Protein-Tyrosine Kinases
;
Gingiva
;
Hand
;
Hedgehogs
;
Immune Sera
;
Immunohistochemistry
;
Keratin-7
;
Mast Cells
;
Molar*
;
Tolonium Chloride
3.Immunohistochemical Observation of Plasma Cell Granuloma in Intraoral Chronic Inflammatory Lesions
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons 2011;33(1):26-31
cathepsin G, cathepsin K, lysozyme, TNFalpha, MMP-2, and MMP-9 in the 14 cases of gingival plasma cell granuloma with immunohistochemical detection were measured to determine the pathogenetic progresses of the plasma cell granuloma compared to the common pyogenic granuloma (n=45) in the gingiva.RESULTS: The gingival lesions of the plasma cell granuloma could be divided into three histological types, plasma cell predominant type (PPT, n=8), mixed inflammatory cell type (MICT, n=2), and sclerosed fibrosis type (SFT, n=4). The PPT showed a condensed infiltration of plasma cells into the perivascular spaces of the granulomatous lesion with frequent formation of Russel's body in their cytoplasm. The MICT showed the concomitant infiltration of many macrophages together with plasma cells, resulting in the diffuse destruction of stromal fibrous tissue. The SFT showed granulomatous lesions replaced gradually by thick collagenous fibrous tissue, resembling an inflammatory pseudotumor. The SFT expressed strongly the lymphocytic markers, CD3 and CD20, and the macrophage/monocyte markers, CD31 and CD68, but showed reduced expression of common inflammatory markers, TNFalpha, cathepsin G, lysozyme, MMP-2, and MMP-9, as well as the reduced expression of osteoclastogenic markers, RANKL and cathepsin K.CONCLUSION: These results suggest that a gingival plasma cell granuloma shows variable gene expression for cell-mediated immunity and stromal tissue degeneration, undergoing sclerotic fibrosis with a persistent inflammatory reaction.]]>
Cathepsin G
;
Cathepsin K
;
Cathepsins
;
Collagen
;
Cytoplasm
;
Fibrosis
;
Gene Expression
;
Gingival Overgrowth
;
Granuloma, Plasma Cell
;
Granuloma, Pyogenic
;
Immunity, Cellular
;
Macrophages
;
Muramidase
;
Myofibroblasts
;
Plasma
;
Plasma Cells
;
Stromal Cells
;
Tumor Necrosis Factor-alpha
4.DNA Vaccines Encoding Toxoplasma gondii Cathepsin C 1 Induce Protection against Toxoplasmosis in Mice.
Yali HAN ; Aihua ZHOU ; Gang LU ; Guanghui ZHAO ; Wenchao SHA ; Lin WANG ; Jingjing GUO ; Jian ZHOU ; Huaiyu ZHOU ; Hua CONG ; Shenyi HE
The Korean Journal of Parasitology 2017;55(5):505-512
Toxoplasma gondii cathepsin C proteases (TgCPC1, 2, and 3) are important for the growth and survival of T. gondii. In the present study, B-cell and T-cell epitopes of TgCPC1 were predicted using DNAstar and the Immune Epitope Database. A TgCPC1 DNA vaccine was constructed, and its ability to induce protective immune responses against toxoplasmosis in BALB/c mice was evaluated in the presence or absence of the adjuvant α-GalCer. As results, TgCPC1 DNA vaccine with or without adjuvant α-GalCer showed higher levels of IgG and IgG2a in the serum, as well as IL-2 and IFN-γ in the spleen compared to controls (PBS, pEGFP-C1, and α-Galcer). Upon challenge infection with tachyzoites of T. gondii (RH), pCPC1/α-Galcer immunized mice showed the longest survival among all the groups. Mice vaccinated with DNA vaccine without adjuvant (pCPC1) showed better protective immunity compared to other controls (PBS, pEGFP-C1, and α-Galcer). These results indicate that a DNA vaccine encoding TgCPC1 is a potential vaccine candidate against toxoplasmosis.
Animals
;
B-Lymphocytes
;
Cathepsin C*
;
Cathepsins*
;
DNA*
;
Epitopes, T-Lymphocyte
;
Immunoglobulin G
;
Interleukin-2
;
Mice*
;
Peptide Hydrolases
;
Spleen
;
Toxoplasma*
;
Toxoplasmosis*
;
Vaccines, DNA*
5.Changes in serum protease and cytokine in patients with silicosis, tuberculosis, and lung cancer.
Rongming MIAO ; Bangmei DING ; Dehong YOU ; Qingjun YOU ; Yingyi ZHANG ; Zhonghua FANG ; Feng GAO ; Guiliang QIAN ; Rong CAO ; Qian XIA ; Yong LI
Chinese Journal of Industrial Hygiene and Occupational Diseases 2015;33(8):598-600
OBJECTIVETo investigate the changes in serum protease and cytokine in patients with silicosis, tuberculosis, and lung cancer.
METHODSSerum samples of patients with silicosis, tuberculosis, and lung cancer were collected. The variation trends of the expression of granzyme A, cathepsin G, apolipoprotein A, and interferon-β (IFN-β) were analyzed using enzyme-linked immunosorbent assay.
RESULTSThe concentration of apolipoprotein A of the silicosis group was 200 µg/ml, significantly higher than those of the tuberculosis and lung cancer groups (P < 0.05), and the lung cancer group had a significantly higher concentration of apolipoprotein A compared with the tuberculosis group (P < 0.05). The silicosis group had significantly higher expression of cathepsin G compared with the tuberculosis and lung cancer groups (P < 0.05), and the tuberculosis group and lung cancer group showed no significant difference in the concentration of cathepsin G (P > 0.05). The tuberculosis group had a significantly higher concentration of granzyme A than the silicosis and lung cancer groups (P < 0.05), and the silicosis group and lung cancer group had similar protein concentration trends (P > 0.05). The tuberculosis group and lung cancer group had significantly higher concentration of IFN-β compared with the silicosis group (P < 0.05), and the tuberculosis group and lung cancer group showed no significant difference in IFN-β concentration (P > 0.05).
CONCLUSIONThis study may offer diagnostic markers for the clinical diagnosis of silicosis, tuberculosis, and lung cancer, and could provide a basis for the research, as well as potential molecular targets for the diagnosis and treatment of these diseases.
Biomarkers ; Cathepsin G ; metabolism ; Cytokines ; blood ; Endopeptidases ; blood ; Enzyme-Linked Immunosorbent Assay ; Granzymes ; metabolism ; Humans ; Interferon-beta ; metabolism ; Lung Neoplasms ; enzymology ; Silicosis ; enzymology ; Tuberculosis ; enzymology
6.Comparative analysis of serum proteomic profiles between patients with silicosis and chronic bronchitis.
Rongming MIAO ; Bangmei DING ; Yingyi ZHANG ; Weimin WU ; Zhonghua FANG ; Rui ZHAO ; Qian XIA ; Yong LI ; Baoli ZHU
Chinese Journal of Industrial Hygiene and Occupational Diseases 2015;33(8):589-591
OBJECTIVETo analyze the differences in serum proteomic profiles between patients with silicosis and chronic bronchitis and to investigate the pathogenesis, clinical diagnosis, and treatment of these two disease.
METHODSSerum samples from patients with stage I silicosis and chronic bronchitis were collected. Two-dimensional gel electrophoresis was performed and protein plots with expression differences higher than 2-fold were identified and further analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
RESULTSCompared with the silicosis group, the chronic bronchitis group had 11 up-regulated proteins and 23 down-regulated proteins. The chronic bronchitis group had high expression of proteins such as interferon beta precursor, apolipoprotein precursor, and transforming growth factor beta1 precursor. The silicosis group had high expression of proteins such as interleukin-6, granzyme A, cathepsin G, and glycoprotein precursor.
CONCLUSIONThe differentially expressed proteins are mainly involved in the activity of serine enzymes, cytotoxicity, inflammation response, and apolipoprotein transfer and play different roles in silicosis and chronic bronchitis.
Bronchitis, Chronic ; pathology ; Cathepsin G ; Down-Regulation ; Electrophoresis, Gel, Two-Dimensional ; Glycoproteins ; Granzymes ; Humans ; Interleukin-6 ; Mass Spectrometry ; Proteomics ; methods ; Serum ; chemistry ; Silicosis ; pathology ; Up-Regulation
7.Protective Effects of Ginger (Zingiber officinale) Extract against Diabetes-Induced Heart Abnormality in Rats.
Behrouz ILKHANIZADEH ; Alireza SHIRPOOR ; Mohamad Hasan KHADEM ANSARI ; Samira NEMATI ; Yusef RASMI
Diabetes & Metabolism Journal 2016;40(1):46-53
BACKGROUND: Diabetic cardiomyopathy is an important causal factor in morbidity and mortality among diabetic patients, and currently, no effective means are available to reverse its pathological progress. The purpose of the present study was to investigate the effect of ginger extract on apolipoproteins (apo) A and B, hyperhomocysteinemia, cathepsin G and leptin changes, as well as cardiac fibrosis and heart muscle cell proliferation under hyperglycemic conditions in vivo. METHODS: Twenty-four male Wistar rats were divided into three groups, namely: control, non-treated diabetic, and ginger extract-treated diabetic groups. The ginger extract-treated diabetic group received a 50 mg daily dose of ginger extract intragastrically for 6 weeks. RESULTS: The results revealed concurrent significant increases in plasma C-reactive protein (CRP), homocysteine (Hcy), cathepsin G and apoB levels and decreases in apoA and leptin levels in the non-treated diabetic group compared to the control group. Moreover, heart structural changes, including fibrosis and heart muscle cell proliferation, were observed in non-treated diabetic rats compared to the control rats. Significant amelioration of changes in the heart structure together with restoration of the elevated levels of Hcy and CRP, leptin, cathepsin G, and apoA and B were found in the ginger extract-treated diabetic group compared to the non-treated diabetic group. CONCLUSION: The findings indicated that ginger extract significantly reduces heart structural abnormalities in diabetic rats and that these effects might be associated with improvements in serum apo, leptin, cathepsin G, and Hcy levels and with the antioxidant properties of ginger extract.
Animals
;
Apolipoproteins A
;
Apolipoproteins B
;
C-Reactive Protein
;
Cathepsin G
;
Diabetic Cardiomyopathies
;
Fibrosis
;
Ginger*
;
Heart Defects, Congenital*
;
Heart*
;
Homocysteine
;
Humans
;
Hyperhomocysteinemia
;
Leptin
;
Male
;
Mortality
;
Myocytes, Cardiac
;
Plasma
;
Rats*
;
Rats, Wistar
8.Over-expression of MMP-3 in the fissured tissue of cleft lip and palate.
Young Wook PARK ; Bong Gi MIN ; Ji Hyuck KIM ; Soung Min KIM ; Young Joon LEE ; Sang Shin LEE ; Suk Keun LEE ; Huck Soo MOON ; Je Geun CHI
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2006;32(1):19-26
OBJECTIVE: In order to elucidate the retrogressive degeneration of orofacial cleft, the fissured tissues of prenatal and postnatal cleft lip and palate were examined by histological and immunohistochemical methods. DESIGN: Totally 42 cases of prenatal (n=17) and postnatal (n=25) cleft lip and/or palate were examined in comparison with 10 cases of normal lip and oral mucosa using immunohistochemical stainings of MMP-3, MMP-9, MMP-10, cathepsin G, PCNA, E-cadherin, TGase 2, HSP-70, vWF, and VEGF. MAIN OUTCOME MEASURES: In the fissured tissue the sebaceous glands were strongly positive for PCNA and grew into the underlying fibromuscular tissue (24/42). Some hyperplastic sebaceous glands of prenatal cleft lip produced infundibular follicular cyst (9/17). The skin and mucosal epithelia from the postnatal cleft lip and palate (10/25) showed severe basal hyperplasia (11/25) and melanocyte infiltration (7/25). RESULTS: The immunostaining of MMP-3 and HSP-70 were strongly positive in the hyperplastic sebaceous glands and nearby atrophying muscle bundles of the fissured tissue, while MMP-9, MMP-10, and cathepsin G were almost negative. The immunoreactions of the other antibodies used in this study were similar between in the fissured tissues and in the normal controls. CONCLUSIONS: These data suggest that the over-expression of MMP-3 is closely related to the sebaceous gland hyperplasia, epithelial dysplasia, and the muscle degeneration, and that the over-expression of MMP-3 in the fissured tissue may continuously aggravate the cleft condition in the later life.
Adult
;
Antibodies
;
Cadherins
;
Cathepsin G
;
Cleft Lip*
;
Follicular Cyst
;
Humans
;
Hyperplasia
;
Lip
;
Melanocytes
;
Mouth Mucosa
;
Outcome Assessment (Health Care)
;
Palate*
;
Proliferating Cell Nuclear Antigen
;
Sebaceous Glands
;
Skin
;
Vascular Endothelial Growth Factor A
9.Effect of thrombin on blood brain barrier permeability and its mechanism.
Jing-Xia GUAN ; Sheng-Gang SUN ; Xue-Bing CAO ; Zhi-Bin CHEN ; E-Tang TONG
Chinese Medical Journal 2004;117(11):1677-1681
BACKGROUNDPrevious studies have indicated that thrombin (TM) may play a major role in brain edema after intracerebral hemorrhages (ICHs). However, the mechanism of TM-induced brain edema is poorly understood. In this study, we explored the effect of TM on the permeability of the blood brain barrier (BBB) and investigated its possible mechanism, aiming at providing a potential target for brain edema therapy after ICHs.
METHODSTM or TM + cathepsin G (CATG) was stereotaxically injected into the right caudate nucleus of Sprague-Dawley rats in vivo. BBB permeability was measured by Evans-Blue extravasation. Brain water content was determined by the dry-wet weight method. Brain microvascular endothelial cells were then cultured in vitro. After TM or TM + CATG was added to the endothelial cell medium, changes in the morphology of cells were dynamically observed by phase-contrast light microscopy, and the expression of matrix metalloproteinase-2 (MMP-2) protein was measured by immunohistochemical method.
RESULTSBBB permeability increased at 6 hours after a TM injection into the ipsilateral caudate nucleus (P < 0.05), peaked between 24 hours (P < 0.01) and 48 hours (P < 0.05) after the injection, and then declined. Brain water content changed in parallel with the changes in BBB permeability. However, at all time points, BBB permeability and brain water content after a TM + CATG injection were not significantly different from the respective parameters in the control group (P > 0.05). TM induced endothelial cell contraction in vitro in a time-dependent manner and enhanced the expression of MMP-2 protein. After incubation with TM + CATG, cell morphology and MMP-2 expression did not change significantly as compared to the control group (P > 0.05).
CONCLUSIONSIncreased BBB permeability may be one of the mechanisms behind TM-induced cerebral edema. TM induces endothelial cell contraction and promotes MMP-2 expression by activating protease activated receptor-1 (PAR-1), possibly leading to the opening of the BBB.
Animals ; Blood-Brain Barrier ; drug effects ; Body Water ; metabolism ; Brain Edema ; etiology ; Cathepsin G ; Cathepsins ; pharmacology ; Cerebral Hemorrhage ; complications ; Matrix Metalloproteinase 2 ; analysis ; Permeability ; Rats ; Rats, Sprague-Dawley ; Receptor, PAR-1 ; physiology ; Serine Endopeptidases ; Thrombin ; toxicity
10.Characterization of HC58cDNA, a putative cysteine protease from the parasite Haemonchus contortus.
Charles I MULEKE ; Yan RUOFENG ; Xu LIXIN ; Sun YANMING ; Li XIANGRUI
Journal of Veterinary Science 2006;7(3):249-255
Because of the complexity of the cathepsin B-like (CBL) family, an information on the biological and biochemical characteristics of individual CBL genes is lacking. In this study, we investigated the degradative effects of the recombinant HC58 protein isolated from Haemonchus contortus parasites on protein substrates over a broad pH range in vitro. This protein, which hydrolyzed the synthetic peptide substrates Z-FR-AMC and Z-RR-AMC, had characteristics of the cysteine protease class of proteins. In the acidic pH range, the isolated protein actively degraded hemoglobin (Hb), the heavy chain of goat immunoglobulin G, and azocasein. By contrast, it degraded fibrinogen in the alkaline pH range. These activities were strongly inhibited in the presence of the cysteine protease inhibitor E-64. While the protein digested Hb, it did not induce the agglutination of erythrocytes from its natural host. These results suggest that the HC58 protein may play a role in the nutrition of this parasite.
Animals
;
Caseins/metabolism
;
Cathepsin B/antagonists&inhibitors/*genetics/isolation & purification/*metabolism
;
Cysteine Proteinase Inhibitors/pharmacology
;
DNA, Complementary/genetics
;
Goat Diseases/*parasitology
;
Goats
;
Haemonchiasis/parasitology/*veterinary
;
Haemonchus/*enzymology/genetics/isolation & purification
;
Hemagglutination Tests/veterinary
;
Hemoglobins/metabolism
;
Hydrogen-Ion Concentration
;
Immunoglobulin G/metabolism
;
Leucine/analogs & derivatives/pharmacology
;
RNA, Helminth/chemistry/genetics
;
Recombinant Proteins/genetics/metabolism
;
Reverse Transcriptase Polymerase Chain Reaction/veterinary